Biosucran - 19104 Philadelphia, PA

Business Name: Biosucran
Categorized In: Research and Development Laboratories
Address: 3711 Market St Floor 8, Philadelphia, PA 19104
Phone Number: (215) 499-7005
Contact Person: Raymond Hamilton
NAICS Code: 541712
SIC Code: 8731
Business Type: B2B (Business to Business)
Founding Year: 2009
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $0 to $49.999
Share This Business:
Similar Businesses: Fibradigm Therapeutics LLC - Philadelphia, PA 19104
Axonia Medical LLC - Philadelphia, PA 19104
Micropathid D Iagnostics LLC - Philadelphia, PA 19104
Myostratum LLC - Philadelphia, PA 19104
Neuronai LLC - Philadelphia, PA 19104
Invidisyn LLC - Philadelphia, PA 19104
Oxygense - Philadelphia, PA 19104
Relgene LLC - Philadelphia, PA 19104
Mem Technologies LLC - Philadelphia, PA 19104
Cellulosic Biotherapeutics LLC - Philadelphia, PA 19104
Translatum LLC - Philadelphia, PA 19104
Sante Biosciences - Philadelphia, PA 19104
Cognizance Biomarkers LLC - Philadelphia, PA 19104
Wilson Robert D MD - Philadelphia, PA 19104
Graphene Frontiers LLC - Philadelphia, PA 19104
Anosos Biotherapeutics LLC - Philadelphia, PA 19104
Sunstone Biosciences Inc - Philadelphia, PA 19104
Quern Therapeutics - Philadelphia, PA 19104
Innofect - Philadelphia, PA 19104
Mitergy LLC - Philadelphia, PA 19104

Biosucran provides professional Research and Development Laboratories from its single location at the coordinates 39.956596,-75.196359.

The company offers B2B variables under the SIC code 8731 and NAICS code 541712, while making an annual revenue of $0 to $49.999 and hiring a total of 1 to 4 employees.

Founded in 2009, the company can now be visited at 3711 Market St Floor 8, Philadelphia, Pennsylvania 19104 or contacted through representative Raymond Hamilton at (215) 499-7005.

For frequently asked questions and further inquiries about professional Research and Development Laboratories, get to know more about Biosucran through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.